Published date: 3 August 2020
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West, Isle of Man, Channel Islands
Value of contract
£2,950,000
Procurement reference
tender_239488/868167
Published date
3 August 2020
Closing date
20 May 2020
Closing time
1pm
Contract start date
1 August 2020
Contract end date
31 July 2021
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
This is an accelerated procedure.
Justification
The COVID-19 outbreak has given rise to an urgent need for the supply of certain generic hospital only medicines where suppliers have terminated or previous tenders have been unable to secure supply, to avoid NHS resources being diverted to source alternative products and ensure continuity. This does not give sufficient time to comply with the standard open procedure timescales for this procurement. The Commercial Medicines Unit considers this to be a state of urgency which it has duly substantiated. Accordingly, the Commercial Medicines Unit is using the accelerated time limits permitted under the Public Contract Regulations 2015 (regulation [27(5) for the open in respect of this procurement.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
NHS National Framework Agreement for the Supply of Generic Pharmaceuticals - Interim 1 2020
Offer reference number: CM/PHG/20/5589
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months (12 months plus options to extend (at the Authority's sole discretion) for up to a further 12 months)
OJEU Reference number: 2020/S 089-213548
Potential periods of call-offs under the framework agreement
Hospital Only Products:
DLS/DNE/DNW 01/08/2020 to 31/07/2021 (12 months)
DLN/DCE/DSW 01/08/2020 to 31/07/2021 (12 months)
More information
Previous notice about this procurement
NHS National Generic Pharmaceuticals Interim 1 2020
- Opportunity
- Published 7 May 2020
Attachments
-
- 200707 Transparency Award Schedule - Interim 1 2020.pdf
- Tender notice
- n/a
-
- Parties Appointed to the Framework & SME status - Interim 1 2020.xlsx
- Tender notice
- n/a
Links
-
- https://nhsengland.bravosolution.co.uk
- Tender notice
- Link to e-sourcing portal
Award information
Awarded date
4 June 2020
Contract start date
1 August 2020
Contract end date
31 July 2021
Total value of contract
£5,226,780.60
This contract was awarded to 1 supplier.
Please see list of awarded suppliers (including SME status) at t
Address
Please see list of awarded suppliers (including SME status) at the following website: https://www.contractsfinder.service.gov.uk
Reference
No reference - other
Supplier is SME?
No
Supplier is VCSE?
No
About the buyer
Contact name
David Ford
Address
2nd Floor, Rutland House
Runcorn
WA7 2ES
England
Share this notice
Closing: 20 May 2020, 1pm
All content is available under the
